Mitsui has exited open source software-focused cybersecurity company Palamida, which had raised $18.5m in funding, in an acquisition by Flexera Software.
Month: October 2016
Unity is provided with $116m
Existing investors WuXi PharmaTech and Mayo Clinic took part in a series B round that will help Unity Biotechnology move preclinical candidates into human trials.
Trinnovate supports four healthcare innovations
Blue Cross Blue Shield of Arizona’s investment subsidiary has backed four healthcare startups since its launch a year ago.
Intel Capital makes Diversity Fund more diverse
The $125m vehicle will now also invest in entrepreneurs from the LGBTQ community, veterans and entrepreneurs living with disabilities.
Ather Energy finds a Hero for $31m investment
Motorcycle manufacturer Hero MotoCorp has committed $31m to electric bike producer Ather Energy in return for a stake of up to 30%.
Myovant raises $218m in year’s biggest biotech IPO
Pfizer, Takeda and BB Biotech invested a combined $88m in the offering, conducted less than five months after Myovant spun out of Roivant Sciences.
Campbell gets in Habit with $32m investment
Personalised nutrition startup Habit has received $32m in funding from Campbell Soup and plans to launch its service early next year.
Amgen gets into eHealth Ventures incubator
The pharmaceutical firm’s European affiliate has joined limited partners including Cleveland Clinic, Maccabi Healthcare Services and Medison Pharma.
Simtoo lands $10.6m in series B round
Renren, which had taken part in the consumer drone producer’s series A round in September 2015, came back to co-lead its series B.
Transamerica covers Hixme in $14m series B
Transamerica has helped health insurance management platform Hixme close its latest funding round at $14.1m, lifting its total funding to $26.6m.
Mobcrush brings together investors to raise $20m
CAA-backed venture Evolution Media Capital has joined a list of Mobcrush shareholders that already includes CAA itself, Lionsgate and Modern Times.
GMI gains $40m in GV-backed series A
GV has participated in a series A round for Genomics Medicine Ireland, joining investors such as the government-owned Ireland Strategic Investment Fund.
Lundbeck helps shore up Bonesupport in $37m round
Existing backer Lundbeckfond Ventures returned to take part in a debt and equity round that took the bone repair technology producer’s total financing past $70m.
Ra Pharmaceuticals IPO brings forth $91.6m
Novo, Novartis and Amgen all recorded exits as blood disorder therapeutics developer Ra floated in the middle of its range.